Popularity #2,725Earnings in 3d
IVA · NASDAQ · Biotechnology

Inventiva (ADR) (IVA)

Developing lanifibranor, an oral MASH candidate, through a pivotal global trial.

$3.56
vs last close−0.09 (−2.60%)